(4-iodophenyl)-[(3S)-3-(methyl-propyl-amino)pyrrolidin-1-yl]methanone | 924643-06-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (4-iodophenyl)-[(3S)-3-(methyl-propyl-amino)pyrrolidin-1-yl]methanone
• 英文别名: (4-iodophenyl)-[(3S)-3-[methyl(propyl)amino]pyrrolidin-1-yl]methanone
• CAS: 924643-06-1
• 化学式: C₁₅H₂₁IN₂O
• 分子量: 372.249
• InChiKey: WIRUZPJRSZNDEM-AWEZNQCLSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  19
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.53
• 拓扑面积：
  23.6
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4-(2-甲基-3-(丙烷-2-基)-3H-咪唑-4-基)嘧啶-2-胺 、 (4-iodophenyl)-[(3S)-3-(methyl-propyl-amino)pyrrolidin-1-yl]methanone 在 palladium diacetate 、 caesium carbonate 、 4,5-双二苯基膦-9,9-二甲基氧杂蒽 作用下， 以 1,4-二氧六环 为溶剂， 生成 [4-[[4-(2-methyl-3-propan-2-yl-3H-imidazol-4-yl)pyrimidin-2-yl]amino]phenyl]-[(3S)-3-(methyl-propyl-amino)pyrrolidin-1-yl]methanone
  参考文献：
  名称：

  The discovery of AZD5597, a potent imidazole pyrimidine amide CDK inhibitor suitable for intravenous dosing

  摘要：

  The development of a novel series of imidazole pyrimidine amides as cyclin-dependent kinase (CDK) inhibitors is described. Optimisation of inhibitory potency against multiple CDK's (1, 2 and 9) resulted in imidazole pyrimidine amides with potent in vitro anti-proliferative effects against a range of cancer cell lines. Excellent physiochemical properties and large margins against inhibition of CYP isoforms and the hERG ion channel were achieved by modi. cation of lipophilicity and amine basicity. A candidate with disease model activity in human cancer cell line xenografts and with suitable physiochemical and pharmacokinetic profiles for intravenous (iv) dosing was selected for further development as AZD5597. (C) 2008 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2008.10.102
• 作为产物：
  描述：

  (4-iodophenyl)-[(3R)-3-methylsulfonyloxypyrrolidin-1-yl]methanone 、 N-甲基正丙胺 生成 (4-iodophenyl)-[(3S)-3-(methyl-propyl-amino)pyrrolidin-1-yl]methanone
  参考文献：
  名称：

  Imidazolyl-Pyrimidine Compounds for Use in the Treatment of Proliferative Disorders

  摘要：

  描述了具有细胞周期抑制活性的化合物，其化学式为（I）。

  公开号：

  US20080280906A1

文献信息

• Imidazolyl-pyrimidine compounds for use in the treatment of proliferative disorders
  申请人：AstraZeneca AB

  公开号：EP2301928A1

  公开（公告）日：2011-03-30

  Compounds of formula (I): which possess cell-cycle inhibitory activity are described.

  式(I)化合物： 所述化合物具有细胞周期抑制活性。
• IMIDAZOLYL-PYRIMIDINE COMPOUNDS FOR USE IN THE TREATMENT OF PROLIFERATIVE DISORDERS
  申请人：AstraZeneca AB

  公开号：EP1912974A1

  公开（公告）日：2008-04-23
• [EN] IMIDAZOLYL-PYRIMIDINE COMPOUNDS FOR USE IN THE TREATMENT OF PROLIFERATIVE DISORDERS<br/>[FR] COMPOSÉS D'IMIDAZOLYL-PYRIMIDINE POUR UNE UTILISATION DANS LE TRAITEMENT D'AFFECTIONS PROLIFÉRANTES
  申请人：ASTRAZENECA AB

  公开号：WO2007015064A1

  公开（公告）日：2007-02-08

  [EN] Compounds of formula (I): which possess cell cycle inhibitory activity are described.
  [FR] La présente invention concerne des composés de formule (I) : qui possèdent une activité inhibitrice du cycle cellulaire.